FLD Q1 2026 Earnings Significant EPS Miss Sends Stock Lower PZG Q1 2026 Earnings Significant EPS Miss Reflects PreRevenue Exploration Stage HLMN Q1 2026 Earnings EPS Misses Estimates Stock Gains on Resilient Demand SAMG Q1 2026 Earnings EPS Misses Estimates by Over 36 Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances